Skip to content
Roboearth – Lifestyle
Author:
SAB Biotherapeutics, Inc.
SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes
March 10, 2026
SAB BIO Reports Full Year 2025 Financial Results and Business Highlights
March 9, 2026
←
Previous Page
1
2